Menlo Advisors LLC Royalty Pharma PLC Transaction History
Menlo Advisors LLC
- $180 Million
- Q2 2024
A detailed history of Menlo Advisors LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Menlo Advisors LLC holds 147,885 shares of RPRX stock, worth $4.17 Million. This represents 2.16% of its overall portfolio holdings.
Number of Shares
147,885Holding current value
$4.17 Million% of portfolio
2.16%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
398Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.24 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$649 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$461 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$338 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...